How are scientists studying neural stem cells for stroke recovery?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Diagram showing the locations of neural stem cells in brain regions such as the hippocampus and ventricles, and hematopoietic stem cells in the bone marrow and blood, with labeled illustrations of the brain, spinal cord, circulatory system, and skeleton. — stem cell Stem cells of neural and hematopoietic origin have tremendous potential in the development of therapies for certain diseases, such as diabetes and Parkinson disease. Neural stem cells occur in the spinal cord and in specific regions of the brain, and hematopoietic stem cells occur in the blood and bone marrow.

Scientists are investigating two primary approaches to using neural stem cells (NSCs) for stroke recovery:

Endogenous Approach: This method focuses on stimulating the patient's own NSCs already present in the body. Researchers administer growth factors—such as erythropoietin, brain-derived neurotrophic factor, and vascular endothelial growth factor—to induce neurogenesis and protect against brain damage. Erythropoietin, in particular, has shown promise in both rat models and preliminary human clinical trials for improving functional recovery.1
Exogenous Approach: This involves extracting stem cells, cultivating them in vitro, and transplanting them into stroke-damaged brain regions. Studies using embryonic stem cells or fetal-derived neural stem cells in rats have demonstrated that these grafts can differentiate into neurons and glial cells, leading to some functional improvement.1

Additionally, researchers are exploring the use of hematopoietic stem cells, which can be mobilized to aid recovery. Despite these advancements, significant challenges remain in controlling cell migration, survival, and integration into existing neuronal networks.1